By Matt Underwood Elon Musk’s company directors have allegedly expressed the feeling of an “expectation” to use drugs with him in order to avoid upsetting the billionaire, according to a recent report. This revelation paints a troubling picture of corporate governance within Musk’s companies and raises questions about the overall stability of such a model.
It is astonishing to think that the use of drugs has become a prerequisite for maintaining a good relationship with the CEO. This volatile behavior exhibited by Musk could, in part, be attributed to his drug use. The real-life version of the Wolf of Wall Street comes to mind, with the drugs explaining his irrationality and unpredictability.
However, relying on drugs to placate someone in a position of power is not a sustainable or healthy approach to corporate governance. It raises serious concerns about the decision-making process within these companies and the overall integrity of their boards. The fact that they awarded Musk a bonus of $50 billion, despite his questionable behavior, is a clear indication of the dysfunctionality of this board.
One can’t help but wonder if those who voted in favor of such a decision were under the influence themselves. The idea that they were “whacked out on meth” during the voting process emphasizes the absurdity of the situation. It also highlights the lack of responsibility and critical thinking exhibited by those in power.
It is disheartening to witness the lengths some individuals will go to maintain their positions of power and wealth. Feeling trapped and miserable, these directors have allowed themselves to become lapdogs to an oligarch. This subservience undermines their integrity and ultimately diminishes trust in any product associated with Musk.
The fact that Musk receives billions of dollars in subsidies while openly using drugs is deeply concerning. It is a clear reminder that we live in a society where the rules for the wealthy and powerful are vastly different from those applied to the average person. The double standards are glaring, and this situation further highlights the need for accountability and transparency.
If these allegations of directors feeling pressured to use drugs with Musk are true, there should be consequences. Their security clearances should be revoked, as using illegal substances should disqualify them from receiving any form of support or subsidy. It is imperative to have individuals of sound judgment and ethical standards in positions of power, especially when national security is at stake.
One can’t help but question the moral compass and mental state of someone who would demand such behavior from their subordinates. Musk’s insistence on engaging in drug use with his directors is not only reckless but also indicative of his disregard for the well-being and professionalism of those around him.
In conclusion, the revelations about Elon Musk’s company directors feeling an “expectation” to use drugs with him paint a distressing portrait of corporate culture and governance. It highlights the need for stronger regulations, accountability, and ethical standards within the business world. It also serves as a cautionary tale, reminding us of the dangers of enabling and turning a blind eye to unethical behavior in those in positions of power.